Partnership Award 2007: Evonik Distinguished by Janssen Pharmaceutica

For the third time now, the Geel, Belgium-based pharmaceutical company Janssen Pharmaceutica has distinguished Evonik Industries AG with the Partnership Award for outstanding service as a supplier. A Johnson & Johnson Group (New Brunswick, New Jersey, USA) company, Janssen Pharmaceutica sources custom-made precious-metal catalysts and intermediates from Evonik for the manufacture of pharmaceutical materials. Each year, the pharmaceutical company conducts a critical review of its suppliers based on quality, logistics, costs, and reliability, and uses the results to evaluate the market advantage of working with each supplier.

Evonik also received the Janssen Partnership Award in 2003 and 2006. “We are pleased to have met the rigorous criteria of Janssen Pharmaceutica again in their 2007 review,” said Dr. Hans-Josef Ritzert, head of the Catalysts Business Line of Evonik Industries. The entire workforce from Research and Development, Production, Customer Service, Sales and Marketing have once again managed to combine high product quality with perfect project management and first-class customer service.

Janssen Pharmaceutica employs 4,700 people at three sites in Beerse, Geel and Olen (Belgium). In Geel, the pharmaceutical company produces the materials for 65 percent of the medicinal products of its U.S. parent company Johnson & Johnson. The products are used in human and veterinary medicine.